Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This multinational, non-interventional, investigator-initiated, retrospective study aims to investigate outcomes of patients, who underwent mitral valve transcatheter edge-to-edge repair (M-TEER) for primary mitral regurgitation (PMR).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| M-TEER | Patients with primary mitral regurgitation undergoing mitral valve transcatheter edge-to-edge repair. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| All-cause mortality | Incidence of death from any cause. | 12 months |
| Cardiovascular mortality | Incidence of cardiovascular death, defined as death attributable to myocardial ischemia and infarction, heart failure, cardiac arrest because of other or unknown cause, or cerebrovascular accident. | 12 months |
| Rehospitalization for congestive heart failure | Incidence of new-onset or worsening signs and symptoms of heart failure that required urgent therapy and resulted in hospitalization, e.g. as assessed by patient interviews or medical records. | 12 months |
| Re-do mitral valve procedure | Incidence of unplanned surgical (mitral valve repair or replacement) or transcatheter re-intervention (re-do transcatheter edge-to-edge repair), e.g. as assessed by patient interviews or medical records. | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Residual mitral regurgitation | Mitral regurgitation severity (0, 1+, 2+, 3+, 4+) as assessed by transthoracic echocardiography at discharge. | up to 30 days |
| Residual mitral regurgitation | Mitral regurgitation severity (0, 1+, 2+, 3+, 4+) as assessed by transthoracic echocardiography at 1-year follow-up. |
Not provided
Inclusion Criteria:
Exclusion Criteria
Not provided
Not provided
Not provided
Consecutive patients undergoing transcatheter edge-to-edge repair for primary mitral regurgitation
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Benedikt Koell, MD | Contact | +4915222815230 | b.koell@uke.de | |
| Sebastian Ludwig, MD | Contact | +491522816168 | se.ludwig@uke.de |
| Name | Affiliation | Role |
|---|---|---|
| Daniel Kalbacher, MD | University Heart & Vascular Center Hamburg | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Montefiore Medical Center | Recruiting | New York | New York | 10467 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008944 | Mitral Valve Insufficiency |
| ID | Term |
|---|---|
| D006349 | Heart Valve Diseases |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| 12 months |
| MVARC (Mitral Valve Academic Research Consortium) Technical success | All of the following must be present:
| 1 day (at exit from the catheterization laboratory) |
| Functional success | If one of the following is present:
| 1 day (at exit from the catheterization laboratory) |
| Centre Hospitalier de Bordeaux | Recruiting | Bordeaux | France |
|
| Université Lille, Inserm, Centre Hospitalier Universitaire de Lille | Recruiting | Lille | France |
|
| University Hospital of Rennes, Centre Hospitalier de Rennes | Recruiting | Rennes | France |
|
| University Heart & Vascular Center Hamburg | Recruiting | Hamburg | 20246 | Germany |
|
| Klinikum der Universität München | Recruiting | Munich | Germany |
|